Quality of Life in Patients with Esophageal Cancer

Thoracic Surgery Clinics

Volumn 23, Issue 4, 2013, Pages 569-575

  Darling, Gail E ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Dysphagia; EORTC QLQ 30; Esophageal cancer; Esophagectomy; FACT E; Health related quality of life; OES 18; Palliation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; CANCER MORTALITY; CANCER PATIENT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTROINTESTINAL QUALITY OF LIFE INDEX; HUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROFILE OF MOOD STATES; QUALITY OF LIFE; QUALITY OF LIFE INDEX; REVIEW; SHORT FORM 36;

DYSPHAGIA; EORTC QLQ-30; ESOPHAGEAL CANCER; ESOPHAGECTOMY; FACT-E; HEALTH-RELATED QUALITY OF LIFE; OES-18; PALLIATION;

CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; PALLIATIVE CARE; QUALITY OF LIFE; SURVIVORS;

EID: 84887114367     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.07.011     Document Type: Review

References (29)

1. McHorney C.A., Ware J.E., Racek A.E. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
2. McHorney C.A., Ware J.E., Lu J.F., et al. The MOS 36 item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66.
3. Groenvold M., Klee M.C., Sprangers M.A., et al. Validation of the EORTC QLQ-30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. JClin Epidemiol 1997, 50:441-450.
4. Blazeby J.M., Conroy T., Hammerlid E., et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003, 39:1384-1394.
5. Cella D.F., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. JClin Oncol 1993, 11:570-579.
6. Darling G., Eton D.T., Sulman J., et al. Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer 2006, 107:854-863.
7. Sanghera S.S., Nurkin S.J., Demmy T.L. Quality of life after an esophagectomy. Surg Clin North Am 2012, 92:1315-1335.
8. Scarpa M., Valente S., Alferi R., et al. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 2011, 17:4660-4674.
9. McLarty A.J., Deschamps C., Trastek V.F., et al. Esophageal resection for cancer of the esophagus: long term function and quality of life. Ann Thorac Surg 1997, 63:1568-1572.
10. de Boer A.G., van Lanschot J.J., van Sandick J.W., et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. JClin Oncol 2004, 22:4202-4208.
11. Headrick J.R., Nichols F.C., Miller D.L., et al. High grade esophageal dysplasia: long terms survival and quality of life after esophagectomy. Ann Thorac Surg 2002, 73:1697-1702.
12. Derogar M., Lagergren P. Health related quality of life among 5 year survivors of esophageal cancer surgery: a prospective population based study. JClin Oncol 2012, 30:413-418.
13. Djarv T., Lagergren P. Six-month post-operative quality of life predicts long term survival after oesophageal cancer. Eur J Cancer 2011, 47:530-535.
14. Djarv T., Metcalfe C., Avery K.N., et al. Prognostic value of changes in health related quality of life scores during curative treatment for esophagogastric cancer. JClin Oncol 2010, 10:1666-1670.
15. Safieddine N., Xu W., Quadri S.M., et al. Health related quality of life in esophageal cancer: effect of neoadjuvant chemoradiotherapy followed by surgical intervention. JThorac Cardiovasc Surg 2009, 137:36-42.
16. Blazeby J.M., Farndon J.R., Donovan J., et al. Aprospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000, 88:1781-1787.
17. Blazeby J.M., Metcalfe C., Nicklin J., et al. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. Br J Surg 2005, 92:1502-1507.
18. Brooks J.A., Kesler K.A., Johnson C.S., et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. JSurg Oncol 2002, 81:185-194.
19. Hurmuzlu M., Aarstad H.J., Aarstad A.K., et al. Health-related quality of life in longer-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer. Dis Esophagus 2011, 24:39-47.
20. Ariga H., Nemoto K., Miyazaki S., et al. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009, 75:348-356.
21. Teoh A.Y., Chiu P.W., Wong T.C., et al. Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation. Ann Surg 2011, 253:1-5.
22. Sundaram A., Geronimo J.C., Willer B.L., et al. Survival and quality of life after minimally invasive esophagectomy: a single surgeon experience. Surg Endosc 2012, 26:168-176.
23. Nafteux P., Moons J., Coosemans W., et al. Minimally invasive oesophagectomy: a valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. Eur J Cardiothorac Surg 2011, 40:1455-1465.
24. Luketich J.D., Alvelo-Rivera M., Buenaventura P.O., et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003, 238:486-494.
25. Derogar M., Orsini N., Sadr-Azodi O., et al. Influence of major postoperative complications on health-related quality of life among long term survivors of esophageal cancer surgery. JClin Oncol 2012, 30:1615-1619.
26. Shenfine J., McNamee P., Steen N., et al. Arandomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 2009, 104:1674-1685.
27. Homs M.Y., Steyerber E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004, 364:1497-1504.
28. Bergquist H., Wenger U., Johnsson E., et al. Stent insertion of endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results a randomized, controlled clinical trial. Dis Esophagus 2005, 18:131-139.
29. Homs M.Y., Kuipers E.J., Siersema P.D. Palliative therapy. JSurg Oncol 2005, 92:246-256.